Verge Genomics Awarded as Technology Pioneer by World Economic Forum
SAN FRANCISCO, June 18, 2020 /PRNewswire-PRWeb/ -- Verge Genomics, the South San Francisco-based company that develops therapies for neurological diseases using machine learning, was selected among hundreds of candidates as one of the World Economic Forum's "Technology Pioneers". The company, co-founded in 2015 by CEO Alice Zhang, aims to shorten the time and cost it takes to discover drugs by using human genomics and machine learning.
The World Economic Forum's Technology Pioneers are early to growth-stage companies from around the world that are involved in the design, development, and deployment of new technologies and innovations, and are poised to have a significant impact on business and society. The Technology Pioneers community is an integral part of the larger Global Innovators community of start-ups at the World Economic Forum.
"We're excited to welcome Verge Genomics to our 20th cohort of Technology Pioneers," says Susan Nesbitt, Head of the Global Innovators Community, World Economic Forum. "Verge Genomics and its fellow pioneers are developing cutting edge technologies all over the world. Beyond their innovations, these firms are contributing greatly to improving the state of the world."
"It's an honor to be acknowledged as a pioneer by the World Economic Forum", said Verge Genomics' Alice Zhang. "It is a confirmation that our platform is among the most innovative in the world and has a chance to improve the lives of many people with neurological diseases. We believe our technology can help decrease both the cost and time it takes to get therapies to the clinic, and we look forward to contributing to the Forum dialogues on this challenge."
Following its selection as Technology Pioneer, CEO Alice Zhang of Verge Genomics will be invited to participate at World Economic Forum activities, events, and discussions throughout the year. Verge Genomics will also contribute to Forum initiatives over the next two years, working with policymakers and private sector leaders to help define the global agenda on key issues.
More Information about this year's Technology Pioneers: Technology Pioneers have been selected based on the community's selection criteria, which includes innovation, impact and leadership as well as the company's relevance with the World Economic Forum's Platforms. Throughout its 20-year run, many Technology Pioneers have continuously contributed to advancement in their industries while some have even gone on to become household names. Past recipients include Airbnb, Google, Kickstarter, Mozilla, Palantir Technologies, Spotify, TransferWise, Twitter and WikimediaWeb. Link: http://wef.ch/techpioneers20
About Verge Genomics: Verge Genomics is focused on developing therapeutics for neurological diseases using human genomics to accelerate drug discovery. Verge has created a proprietary all-in-human platform, generating one of the field's largest and most comprehensive databases of ALS and Parkinson's Disease patient genomic data. The Company is led by experienced computational biologists and drug developers who are successfully advancing therapeutic programs in ALS and Parkinson's disease toward the clinic. For additional information, please visit http://www.vergegenomics.com.
About World Economic Forum: The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business and other leaders of society to shape global, regional and industry agendas. Link: http://www.weforum.org
About the Global Innovators: The Global Innovators Community is a group of the world's most promising start-ups and scale-ups that are at the forefront of technological and business model innovation. The World Economic Forum provides the Global Innovators Community with a platform to engage with public- and private-sector leaders and to contribute new solutions to overcome current crises and build future resiliency.
SOURCE Verge Genomics
